Follow The Filings

SEPN Septerna

Septerna earnings company data as of 4:47 AM ET 10/24

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 9 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by SEPN's executives, directors and 10% owners in the last 12 months, from their Form 4s

All SEPN insider trades
  • None no insider bought on the open market
  • $63.5M sold by 2 insiders outside a trading plan
  • $12.7M sold by 4 insiders under 10b5-1 plans
  1. Elizabeth Bhatt COO
    Planned sale
    $150K 4,000 shares at $37.41 2.2% of stake
    Traded Oct 15 Filed Oct 19
    ↗
  2. Daniel D. Long SVP, Drug Discovery
    Planned sale
    $126K 3,333 shares at $37.83 3.3% of stake
    Traded Sep 1 Filed Sep 3
    ↗
  3. Ra Capital Management, L.P. Director, +4 joint filers
    Sale
    $63.5M 1,493,000 shares at $42.50 67% of stake
    Traded Aug 12 Filed Aug 14
    ↗
  4. Third Rock Ventures V, L.P. 10% owner, +5 joint filers
    Planned sale
    $7.4M 147,200 shares at $50.27 2.4% of stake
    Traded Aug 12 Filed Aug 14
    ↗
  5. Elizabeth Bhatt COO
    Planned sale
    $1.1M 25,000 shares at $44.00 13% of stake
    Traded Aug 11 Filed Aug 13
    ↗
  6. Daniel D. Long SVP, Drug Discovery
    Planned sale
    $115K 3,334 shares at $34.47 3.3% of stake
    Traded Aug 3 Filed Aug 5
    ↗
  7. Elizabeth Bhatt COO
    Planned sale
    $136K 4,000 shares at $33.99 2.2% of stake
    Traded Jul 15 Filed Jul 17
    ↗
  8. Daniel D. Long SVP, Drug Discovery
    Planned sale
    $115K 3,333 shares at $34.36 3.3% of stake
    Traded Jul 1 Filed Jul 2
    ↗
  9. Samira Shaikhly Chief People Officer
    Planned sale
    $77K 2,178 shares at $35.18 73% of stake
    Traded Jun 29 Filed Jun 30
    ↗
  10. Daniel D. Long SVP, Drug Discovery
    Planned sale
    $533K 15,000 shares at $35.51 14% of stake
    Traded Jun 22 Filed Jun 24
    ↗
  11. Samira Shaikhly Chief People Officer
    Planned sale
    $219K 6,250 shares at $35.08 89% of stake
    Traded Jun 12 Filed Jun 16
    ↗
  12. Samira Shaikhly Chief People Officer
    Planned sale
    $172K 5,935 shares at $28.93 88% of stake
    Traded Jun 1 Filed Jun 3
    ↗
  13. Samira Shaikhly Chief People Officer
    Planned sale
    $355K 11,798 shares at $30.06 94% of stake
    Traded May 26 Filed May 28
    ↗
  14. Elizabeth Bhatt COO
    Planned sale
    $97K 4,000 shares at $24.34 2.2% of stake
    Traded Apr 15 Filed Apr 17
    ↗
  15. Samira Shaikhly Chief People Officer
    Planned sale
    $2M 70,453 shares at $28.10 99% of stake
    Traded Mar 2 Filed Mar 4
    ↗

Also filed in the last 12 months, not counted as buying or selling: 21 option exercises.

SEC filings

Recent issuer filings from EDGAR, 15 shown.

Filed Form Detail Links
8-K 7.01,8.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13D/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.07 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc

Source: SEC EDGAR submissions, updated 4 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.